Allergan Q1 net earnings decrease to $45m
Allergan, a multi-specialty healthcare company, has reported net earnings of $45m for the first quarter of 2009, compared to $107.9m for the first quarter of 2008. Allergan has
Cellares and GenomeFrontier Therapeutics have announced a collaboration to assess automated manufacturing for the latter’s investigational CAR-T cell therapy, GF-CART01, on the Cell Shuttle platform.